by Lyla El-Fayomi | Dec 26, 2024
Pick of the Month Another HIV-1 remission, but with a twist: The Geneva Patient I previously wrote about Mr. Paul Edmonds, who was the fifth person in history to be cured of both HIV-1 and leukemia since the first such case in 2009. This was achieved through a...
by Sara M. Nolte | Dec 19, 2024
I’m excited to be sharing some new Canadian cancer immunotherapy developments! We’ve already seen some great stuff with CAR T cells and checkpoint inhibitors. But the strength of these therapies is also their downfall: their targets make them highly specific and...
by Laya Kiani | Dec 12, 2024
The convergence of tissue engineering, regenerative medicine (TERM) and artificial intelligence (AI) has ushered in a transformative era for the biomedical field. By leveraging machine learning (ML) and deep learning (DL), researchers can enhance cell culture...
by Anis Fahandej-Sadi | Dec 5, 2024
If you’re reading this, you’re probably aware of the massive strides the cell and gene therapy (CGT) industry has made in the last few years. Between 2017 and 2022, six CGT products were approved by the U.S. Food and Drug Administration, but we saw eight approvals in...
by Stacey Johnson | Nov 29, 2024
Are you familiar with the Gartner Hype Cycle? It’s a way of separating reality from hype when it comes to emerging technologies – like cell and gene therapies (CGTs). The hype cycle employs a graph to present the maturity of new technologies as they pass through five...
by Lyla El-Fayomi | Nov 19, 2024
Millions of placentas are discarded annually around the world. Given the regenerative medical potential demonstrated by placenta-derived tissue over the years, this is quite an unfortunate statistic. First used in 1910, placenta-derived tissue was abandoned in the...
by Lyla El-Fayomi | Nov 14, 2024
I’ve once again divided up the October edition of RMNU🔬 by trending research topic. Read on for remarkable placental science, new research involving in vivo genetic engineering, and more! Trend of the month: Healing via placenta Millions of placentas are discarded...
by Laine Bodnar | Oct 31, 2024
As a member of CCRM’s Communications team, I am always keen to learn about the different ways that communication can bridge the knowledge gap between various stakeholders and complex scientific work and discoveries in regenerative medicine. Known as scientific...
by Stacey Johnson | Oct 25, 2024
Michel Sadelain is the 2024 Gairdner International Award laureate, along with Dr. Zelig Eshhar, for his “seminal contributions to the conception, development and application of CD19-CAR T cell therapy for cancer.” It’s been a good year for Dr. Sadelain, who also won...
Comments